Capstone Investment Advisors »

Janux Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 52k 37.65

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
Avidity Partners Management
Goldman Sachs Group
Samlyn Capital

View all funds holding Janux Therapeutics